Ref.: BL-RE-091241Manufacturer ref.: EH277RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human ILT-2/LIR-1/CD85j quantitates human ILT-2/LIR-1/CD85j in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ILT-2/LIR-1/CD85j.
Accession number
Membre de la famille similaire à l’antigène CD85 J ; CD85j ; transcription similaire à l’Ig 2 ; ILT2 ; ILT-2 ; transcription similaire à l’immunoglobuline 2 ; récepteur similaire à l’Ig leucocytaire B1 ; récepteur similaire à l’immunoglobuline leucocytaire B1 ; membre de la sous-famille B des récepteurs similaire à l’immunoglobuline leucocytaire 1 ; isoforme soluble des membres de la sous-famille B des récepteurs similaire à l’immunoglobuline leucocytaire 1 ; membre de la sous-famille B des récepteurs similaire à l’immunoglobuline leucocytaire de type 3 (avec domaines TM et ITIM), membre 1 ; LILRB1 ; LIR1 ; LIR-1 ; LOC100912456 ; MIR7 ; MIR-7 ; récepteur similaire à l’immunoglobuline monocyte/macrophage 7 ; récepteur inhibiteur myéloïde 7 ; PIRB ; PIR-B
Dose range
22 to 5.000 pg/ml
Sensitivity of the dosage
22 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human ILT-2/LIR-1/CD85j quantitates human ILT-2/LIR-1/CD85j in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ILT-2/LIR-1/CD85j.
Human ILT-2/LIR-1/CD85j quantitates human ILT-2/LIR-1/CD85j in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ILT-2/LIR-1/CD85j.
This gene is part of the family of leukocyte immunoglobulin receptors (LIR), which is found in a group of genes in the chromosome region 19q13.4. The coded protein belongs to class B of the LIR receptor subfamily containing two or four extracellular domains of immunoglobulin, one transmembrane domain and two to four tyrosine-based cytoplasmic immunoreceptor inhibitory (ITIM) motifs. The receptor is expressed on immune cells where it binds to the MHC Class I molecules on antigen cells and transduces a negative signal that inhibits stimulation of an immune reaction. It is thought that inflammatory responses and cytotoxicity should be controlled to help concentrate the immune response and limit self-reactivity. Several transcription variants coding different isoforms were found for this gene.
Sensitivity
Sensitivity of the dosage: 22 pg/ml.
Measurement range
Dose range: 22 to 5,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: CD85j (ILT2).
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; Serum, 50 µl; Plasma, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17185039
Specifications
Accession number
Member of the family similar to CD85 J antigen; CD85j; transcription similar to l-Ig 2; ILT2; ILT-2; transcript similar to l-immunoglobulin 2; receptor similar to l-Ig-leukocyte B1; receptor similar to l-immunoglobulin-leukocyte B1; subfamily B-receptor